GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (LSE:GSK) » Definitions » Float Percentage Of Total Shares Outstanding

GSK (LSE:GSK) Float Percentage Of Total Shares Outstanding : 99.97% (As of Dec. 15, 2024)


View and export this data going back to 1972. Start your Free Trial

What is GSK Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GSK's float shares is 4,079.41 Mil. GSK's total shares outstanding is 4,080.52 Mil. GSK's float percentage of total shares outstanding is 99.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GSK's Insider Ownership is 0.20%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GSK's Institutional Ownership is 42.98%.


GSK Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

GSK's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=4,079.41/4,080.52
=99.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GSK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (LSE:GSK) » Definitions » Float Percentage Of Total Shares Outstanding
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.